Cancer Stem Cell News Volume 9.33 | Sep 2 2020


    2020-09-02 | CSCN 9.33

    Cancer Stem Cell News by STEMCELL Technologies
    Vol. 9.33 – 2 September, 2020

    Wnt Activation as a Therapeutic Strategy in Medulloblastoma

    By using primary patient-derived medulloblastoma (MB) brain tumor-initiating cell lines, investigators characterized differences in the tumor-initiating capacity of Wnt, group three, and group four MB.
    [Nature Communications]

    AbstractPress Release

    Resources for Your T Cell Therapy Research
    PUBLICATIONSRanked by the impact factor of the journal

    Model of Patients with Liver Cancer Based on Tumor Stem Cell Content and Immune Process

    Scientists used RNA-seq and clinical data of liver hepatocellular carcinoma from The Cancer Genome Atlas, Estimation of Stromal and Immune cells in Malignant Tumours, mRNA stemness index score, and weighted gene correlation network analysis methods to find genes significantly linked to the degree of immune infiltration and content of tumor stem cells.

    Full Article

    Poor Proteasomal Function with Radioiodine Eliminates CT26 Colon Cancer Stem Cells Resistant to Bortezomib Therapy

    Tumor response to conventional bortezomib treatment was enhanced by targeted radiotherapy of resistant cancer stem cells that had characteristically poor proteasome function.
    [Scientific Reports]

    Full Article

    Distribution of Lactate and the Monocarboxylate Transporters 1 and 4 in Human Glioblastoma Multiforme and Their Relationships to Tumor Progression-Associated Markers

    Researchers found the existence of individual differences in the regional distribution of monocarboxylate transporters 1 and 4 and suggested that both transporters had distinct connections to glioblastoma multiforme progression processes.
    [International Journal of Molecular Sciences]

    Full Article

    Lymph Liquid Biopsy for Detection of Cancer Stem Cells

    Scientists introduced lymph liquid biopsy through collection of peripheral and central lymph samples and demonstrated its feasibility for detection of stem‐like circulating tumor cells potentially responsible for metastasis development and tumor relapse.
    [Cytometry Part A]


    Promotes Self-Renewal of Gastric Cancer Cells by Inhibiting Expression of L-PTGDS and PTGDR2

    Researchers revealed a novel function of Yes-associated protein 1 (YAP) and the mechanism underlying cancer stem cell regulation by YAP.
    [International Journal of Clinical Oncology]


    and Gene Mutation Verification of Circulating Tumor Cells of Lung Cancer with Epidermal Growth Factor Receptor Peptide Lipid Magnetic Spheres

    Investigators identified an efficient, simple, and specific method of detecting mutations in the epidermal growth factor receptor gene in isolated lung cancer circulating tumor cells and to improve the ability to obtain tumor tissue clinically.
    [Thoracic Cancer]

    Full Article

    of Akt Phosphorylation Is a Key to Targeting Cancer Stem-Like Cells by mTOR Inhibition

    Scientists established a CD133+ cell-rich subline from Capan-1 pancreatic cancer cells as a pancreatic cancer stem cell model and compared the effects of KU-0063794, a dual mTORC1/mTORC2 inhibitor, against those of mTORC1-specific rapamycin.
    [Human Cell]


    the Colon Cancer Cells Sensitivity toward Radiation Therapy via Application of Oct4–Sox2 Complex Decoy Oligodeoxynucleotides

    Cellular uptake and localization assays demonstrated that decoy Oct4–Sox2 complex decoy oligodeoxynucleotides could efficiently be transfected to the cells and resided in the subcellular compartment, where they posed their action on gene regulation.
    [Molecular Biology Reports]


    How have LSCs changed our understanding of myeloid malignancies? Webinar by Dr. Christopher Park, NYU

    The Potential Role of YAP in Head and Neck Squamous Cell Carcinoma

    The authors discuss the causes and functional consequences of YAP dysregulation in head and neck squamous cell carcinoma (HNSCC). They also address interactions between YAP and other oncogenic drivers of HNSCC.
    [Experimental and Molecular Medicine]

    Full Article

    Vitamin D Effects on Cell Differentiation and Stemness in Cancer

    Scientists revise the current knowledge of the molecular and genetic basis of the regulation by 1,25(OH)2D3 of the differentiation and stemness of human carcinoma cells, cancer-associated fibroblasts and cancer stem cells.

    Full Article

    Role and Specific Mechanism of OCT4 in Cancer Stem Cells: A Review

    The authors illustrate the mechanism by which OCT4 plays a role in cancer stem cells from the perspective of genetic modification of OCT4, non-coding RNA, complexes and signaling pathways associated with OCT4.
    [International Journal of Stem Cells]

    Full Article


    Food and Drug Administration Approves Onureg® (Azacitidine Tablets), a New Oral Therapy, as Continued Treatment for Adults in First Remission with Acute Myeloid Leukemia

    The FDA has approved Onureg® for the continued treatment of adult patients with acute myeloid leukemia who achieved first complete remission (CR) or CR with incomplete blood count recovery following intensive induction chemotherapy and who was not able to complete intensive curative therapy.
    [Bristol Myers Squibb]

    Press Release


    From Stem Cells to Human Development

    September 8 – 11

    > See All Events


    Postdoctoral Fellow – Immunology, Genetics, Precision Medicine

    St. Anna Children’s Cancer Research Institute – Vienna, Austria

    Postdoctoral Associate – RNA Epigenetics in Cancer Stem Cells

    Sanford Burnham Prebys Medical Discovery Institute – La Jolla, California, United States

    Faculty Position – Prostate Cancer Biology and Cancer Epigenetics

    Northwestern University – Chicago, Illinois, United States

    Postdoctoral Fellowship – Hematopoiesis, Leukemia, and Bone Marrow Failure Syndromes

    The University of Texas Southwestern Medical Center – Dallas, Texas, United States

    Postdoctoral Research Fellow – Hematopoiesis, Marrow Failure and Myeloid Leukemia

    Cincinnati Children’s Hospital Medical Center – Cincinnati, Ohio, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Science News Cancer Stem Cell News
    Archives Contact Us
    Cancer Stem Cell News Twitter